Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein-Reference-Cited by-同舟云学术

Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein

Published:2014-04-30 Issue:234 Volume:6 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Jiang Liwei¹,Wang Nianshuang²,Zuo Teng¹³,Shi Xuanling¹,Poon Kwok-Man Vincent⁴,Wu Yongkang⁵,Gao Fei¹,Li Danyang¹,Wang Ruoke¹,Guo Jianying¹,Fu Lili¹,Yuen Kwok-Yung⁴,Zheng Bo-Jian⁴,Wang Xinquan²,Zhang Linqi¹

Affiliation:

1. Comprehensive AIDS Research Center, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Medicine, Tsinghua University, Beijing 100084, China.

2. Ministry of Education Key Laboratory of Protein Science, Center for Structural Biology, School of Life Sciences, Tsinghua University, Beijing 100084, China.

3. School of Life Sciences, Tsinghua University, Beijing 100084, China.

4. Department of Microbiology, The University of Hong Kong, Hong Kong, China.

5. Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.

Abstract

Human neutralizing monoclonal antibody could serve as a therapeutic intervention against MERS-CoV infection.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference49 articles.

1. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic;Chan J. F.;65,2012

2. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012

3. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group

4. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

5. State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans.;The WHO MERS-CoV Research Group;PLOS Curr.,2013

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans;Cell Reports;2024-08

2. A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses;2024-07-01

3. Developments in treatment for middle east respiratory syndrome coronavirus (MERS-CoV);Expert Review of Respiratory Medicine;2024-05-03

4. An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation;Nature Communications;2024-04-20

5. Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans;2024-04-02